Skip to content

Study on the Infusion of Umbilical Cord Blood Mononuclear Cells to Aid Chemotherapy for Gastrointestinal Tumors

Study on the Infusion of Umbilical Cord Blood Mononuclear Cells to Aid Chemotherapy for Gastrointestinal Tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108316
Enrollment
Unknown
Registered
2025-08-28
Start date
2024-08-14
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive tract tumors that cannot be treated with radical surgery or recurrence and metastasis after surgery

Interventions

Umbilical cord blood mononuclear cell infusion combing with chemotherapy group:Infusion of Umbilical cord blood mononuclear cell

Sponsors

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Age from 18 years old to 70 years old; 2.Patients diagnosed with digestive tract tumors that cannot be treated with radical surgery or recurrence and metastasis after surgery; 3.Karnofsky score greater than 60; 4.Voluntarily participate in this study and sign the informed consent form;

Exclusion criteria

Exclusion criteria: 1.Having severe mental illness; 2.Having heart, lung, kidney and other organ failure; 3.Severe infections requiring intravenous antibiotics, antifungal or antiviral therapy; 4.Combining with other fatal and dangerous diseases; 5.Vulnerable groups, including people with mental illness, cognitive impairment, critically ill patients, minors, pregnant women, illiterates, etc;

Design outcomes

Primary

MeasureTime frame
Number of peripheral blood immune cells (T cell subsets, B cells, and NK cells);Subject's quality of life;Serum complement and immunoglobulin content were examined;

Secondary

MeasureTime frame
PFS;ORR;OS;RPS;

Countries

China

Contacts

Public ContactZhiwei Liu

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University

lzwsrrsh@163.com+86 13605808354

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026